her semaglutide Ask Leyla: Where do you stand on GLP-1 weight loss drugs? Hims & Hers copies Novo
Description
If your research interest is specifically in amylin receptor activation, cagrilintide is currently the only viable long-acting option
It is also injected once a week
doi: 10.3233/JAD-2010-1314 [DOI] [PMC free article] [PubMed] [Google Scholar] 152
It is administered as a subcutaneous injection and has been associated with significant and sustained weight loss when used in combination with lifestyle modifications
This results in a lower metabolic rate and the "skinny-fat" look
This means it mimics the action of the GLP-1 hormone naturally made in the gut
